298 related articles for article (PubMed ID: 7004633)
41. The contribution of a serum component(s) modified by B cells to the mechanism for macrophage activation by liposomes.
Aramaki Y; Murai M; Tsuchiya S
Immunology; 1993 Oct; 80(2):253-8. PubMed ID: 8262553
[TBL] [Abstract][Full Text] [Related]
42. Improvement of iron removal from the reticuloendothelial system by liposome encapsulation of N,N'-bis[2-hydroxybenzyl]-ethylenediamine-N,N'-diacetic acid (HBED). Comparison with desferrioxamine.
Lau EH; Cerny EA; Wright BJ; Rahman YE
J Lab Clin Med; 1983 May; 101(5):806-16. PubMed ID: 6403640
[TBL] [Abstract][Full Text] [Related]
43. The production of a macrophage-activating factor from rainbow trout Salmo gairdneri leucocytes.
Graham S; Secombes CJ
Immunology; 1988 Oct; 65(2):293-7. PubMed ID: 3056854
[TBL] [Abstract][Full Text] [Related]
44. Identification of a macrophage-activating factor in granules of the RNK large granular lymphocyte leukemia.
Roussel E; Greenberg AH
J Immunol; 1989 Jan; 142(2):543-8. PubMed ID: 2642945
[TBL] [Abstract][Full Text] [Related]
45. Human alveolar macrophages: potentiation of their tumoricidal activity by liposome-encapsulated muramyl dipeptide.
Sone S; Tsubura E
J Immunol; 1982 Sep; 129(3):1313-7. PubMed ID: 7108208
[TBL] [Abstract][Full Text] [Related]
46. Potential value of liposomes containing muramyl dipeptide for augmenting the tumoricidal activity of human alveolar macrophages.
Sone S; Tachibana K; Shono M; Ogushi F; Tsubura E
J Biol Response Mod; 1984; 3(2):185-94. PubMed ID: 6726281
[TBL] [Abstract][Full Text] [Related]
47. IFN-beta-induced reduction of superoxide anion generation by macrophages.
Boraschi D; Ghezzi P; Salmona M; Tagliabue A
Immunology; 1982 Apr; 45(4):621-8. PubMed ID: 6175565
[TBL] [Abstract][Full Text] [Related]
48. In vitro induction of tumoricidal and suppressor macrophages by lymphokines: possible feedback regulation.
Taramelli D; Holden HT; Varesio L
J Immunol; 1981 Jun; 126(6):2123-8. PubMed ID: 6453155
[TBL] [Abstract][Full Text] [Related]
49. Mechanism of macrophage-mediated cytotoxicity: production of a soluble cytotoxic factor.
Drysdale BE; Zacharchuk CM; Shin HS
J Immunol; 1983 Nov; 131(5):2362-7. PubMed ID: 6415164
[TBL] [Abstract][Full Text] [Related]
50. Characterization of human macrophage activation factor (MAF) prepared from antigen-stimulated lymphocytes.
Cameron DJ
J Clin Lab Immunol; 1984 Jan; 13(1):47-50. PubMed ID: 6371237
[TBL] [Abstract][Full Text] [Related]
51. Liposomes for targeting of antigens and drugs: immunoadjuvant activity and liposome-mediated depletion of macrophages.
van Rooijen N
J Drug Target; 2008 Aug; 16(7):529-34. PubMed ID: 18686122
[TBL] [Abstract][Full Text] [Related]
52. The tumoricidal properties of inflammatory tissue macrophages and multinucleate giant cells.
Poste G
Am J Pathol; 1979 Aug; 96(2):595-610. PubMed ID: 382866
[TBL] [Abstract][Full Text] [Related]
53. Cytotoxicity of human macrophages for tumor cells: enhancement by bacterial lipopolysaccharides (LPS).
Cameron DJ; Churchill WH
J Immunol; 1980 Feb; 124(2):708-12. PubMed ID: 7356710
[TBL] [Abstract][Full Text] [Related]
54. Modulation of the activity of sea bass (Dicentrarchus labrax) head-kidney macrophages by macrophage activating factor(s) and lipopolysaccharide.
Sarmento A; Marques F; Ellis AE; Afonso A
Fish Shellfish Immunol; 2004 Feb; 16(2):79-92. PubMed ID: 15123313
[TBL] [Abstract][Full Text] [Related]
55. Macrophage activation and generation of tumoricidal activity by liposome-associated human C-reactive protein.
Barna BP; Deodhar SD; Gautam S; Yen-Lieberman B; Roberts D
Cancer Res; 1984 Jan; 44(1):305-10. PubMed ID: 6690042
[TBL] [Abstract][Full Text] [Related]
56. Possible involvement of macrophage-mediated hepatocytotoxicity in chronic active hepatitis: the induction of liver cell injury by culture supernatant of MAF-activated macrophages.
Mizoguchi Y; Shiba T; Ohnishi F; Monna T; Yamamoto S; Nakai K; Otani S; Morisawa S
Hepatogastroenterology; 1981 Oct; 28(5):254-7. PubMed ID: 7047339
[TBL] [Abstract][Full Text] [Related]
57. Modification of alpha 2-macroglobulin into a macrophage-activating factor through the action of liposome-stimulated B-cell membranous glycosidases.
Murai M; Aramaki Y; Tsuchiya S
Immunology; 1995 Sep; 86(1):58-63. PubMed ID: 7590882
[TBL] [Abstract][Full Text] [Related]
58. Studies on the activation of mouse bone marrow-derived macrophages by the macrophage cytotoxicity factor (MCF).
Meerpohl HG; Lohmann-Matthes ML; Fischer H
Eur J Immunol; 1976 Mar; 6(3):213-7. PubMed ID: 1086777
[TBL] [Abstract][Full Text] [Related]
59. Immune cell-mediated antitumor activities of GD2-targeted liposomal c-myb antisense oligonucleotides containing CpG motifs.
Brignole C; Pastorino F; Marimpietri D; Pagnan G; Pistorio A; Allen TM; Pistoia V; Ponzoni M
J Natl Cancer Inst; 2004 Aug; 96(15):1171-80. PubMed ID: 15292389
[TBL] [Abstract][Full Text] [Related]
60. Macrophage activation for tumor cytotoxicity: induction of macrophage tumoricidal activity by lymphokines from EL-4, a continuous T cell line.
Meltzer MS; Benjamin WR; Farrar JJ
J Immunol; 1982 Dec; 129(6):2802-7. PubMed ID: 6982943
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]